Taiwan's COVID vaccines about to enter phase 2 clinical trials: FDA

A number of COVID-19 vaccines developed in Taiwan have completed the first phase of clinical trials and are likely to enter phase 2 trials by the end of the year, the nation's Food and Drug Administration (FDA) said Wednesday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)